Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2026-01-08 @ 9:41 AM
Study NCT ID:
NCT03336333
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-07
First Post:
2017-11-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL
Sponsor:
BeiGene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-31
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-09
Completion Date Type:
ESTIMATED
First Submit Date:
2017-11-01
First Submit QC Date:
None
Study First Post Date:
2017-11-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-10-16
Results First Submit QC Date:
None
Results First Post Date:
2023-11-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-17
Last Update Post Date:
2025-03-07
Last Update Post Date Type:
ACTUAL